Meeting
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Clonality of T-cell repertoire in the tumor microenvironment (TME) and peripheral blood of metastatic melanoma patients treated with CTLA4 blockade and interferon-α (IFN).
Authors
Ahmad A. Tarhini
University of Pittsburgh Cancer Institute, Pittsburgh, PA
Ahmad A. Tarhini, Aya Agha, Zahra Rahman, Sharon Benzeno, Erik Yusko, Priyanka Vallabhaneni
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Biomarkers and Inflammatory Signatures,Humoral Immunity for Diagnosis and Therapy,Immune Checkpoints and Stimulatory Receptors,Modulating Innate Immunity,Therapies Targeting T cells
Sub Track
Clinical Trials
Clinical Trial Registration Number
NCT00610857
Citation
J Clin Oncol 35, 2017 (suppl 7S; abstract 9)
DOI
10.1200/JCO.2017.35.7_suppl.9
Abstract #
9
Poster Bd #
B2
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Breakthrough
Investigation of a tamoxifen-RACK7/KDM5C-IFN-I axis for ER+ breast cancer immunomodulation.
First Author: Marvin Angelo Esteban Aberin
Poster
2023 ASCO Annual Meeting
Phase II trial of BXCL701 and pembrolizumab in patients with metastatic pancreatic ductal adenocarcinoma (EXPEL-PANC).
First Author: Benjamin Adam Weinberg
Poster
2020 ASCO Virtual Scientific Program
Clinical value of noninvasive biomarkers reflecting a collagen-rich stroma in metastatic melanoma patients treated with anti-PD1 therapy.
First Author: Christina Jensen
Poster
2020 ASCO Virtual Scientific Program
Integrated biomarker study of neoadjuvant pepinemab and nivolumab in patients with resectable metastatic melanoma.
First Author: Michael C. Lowe